Con Konstantopoulos, Akesa

Con konstantopoulos

Co-Founder and Co-CEO

Connect on LinkedIn

With over two decades in the pharmaceutical industry, Con Konstantopoulos has deep knowledge and experience in managing international pharmaceutical supply chains.

  • Akesa supports inclusion at FIDA 2024 Grand Final Day

    Akesa has announced its support for The Football Integration Development Association (FIDA) 2024 Grand Final Day.

  • Federal Budget 2024-25: Key outcomes for Australian clinical trial sector

    The Australian Federal Budget for FY24-25 has outlined significant funding and initiatives to support the health sector, with a strong focus on clinical trials and medical research. Explore the key outcomes that will impact the clinical trial sector in Australia.

  • Optimising clinical trial supply

    In clinical trial supply, the journey from pharmaceutical product inception to clinical trials is multifaceted. Explore the steps involved in the clinical trial supply chain and the key considerations to a successful clinical trial.

  • Akesa awarded EcoVadis sustainability rating

    Akesa has been awarded a bronze sustainability rating from EcoVadis in recognition of its commitment to sustainable and ethical business practices, and environmental stewardship.

    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.